Literature DB >> 2112469

A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.

S Munkvad1, J Gram, J Jespersen.   

Abstract

The balance between the coagulation system generating fibrin and its subsequent removal by the fibrinolytic system determines the fate of fibrin deposited in the vascular system. In a prospective study, selected haemostatic variables assessing this balance were determined in plasma samples from 20 consecutive patients admitted with unstable angina pectoris. Over a follow-up period of 6 years, eight patients developed myocardial infarction, whereas 12 patients did not. There was no significant difference between the two groups in the median plasma concentrations of thrombin-antithrombin III complexes reflecting the coagulant activity. The infarction group was characterized by a significantly lower median activity of tissue plasminogen activator in plasma euglobulins (P less than 0.05), a higher median concentration of tissue plasminogen activator antigen in plasma (P less than 0.05) and a tendency to higher plasma levels of antigenic and functional plasminogen activator inhibition. In all patients, the activities of tissue plasminogen activator inhibitor and of tissue plasminogen activator were significantly associated (rs = -0.4811, P less than 0.05). We conclude that a depressed fibrinolytic capacity attributable to a low tissue plasminogen activator activity is of pathogenetic importance for the development of myocardial infarction in patients with unstable angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112469     DOI: 10.1093/oxfordjournals.eurheartj.a059745

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

Review 1.  Fibrinolytic function and coronary risk.

Authors:  I Juhan-Vague; P Morange; M Christine Alessi
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

2.  Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

3.  Relationship between job stress and plasma fibrinolytic activity in male Japanese workers.

Authors:  M Ishizaki; I Tsuritani; Y Noborisaka; Y Yamada; M Tabata; H Nakagawa
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

4.  Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction.

Authors:  J H Jansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors:  A J Wagstaff; J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

6.  Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis.

Authors:  Jaume Figueras; Jasone Monasterio; Enric Domingo; Beatriz Meneses; Elsa Nieto; Josefa Cortadellas; David Garcia-Dorado
Journal:  Thromb J       Date:  2011-05-27

7.  An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1.

Authors:  Ze Zheng; Lalitha Nayak; Wei Wang; Arif Yurdagul; Xiaobo Wang; Bishuang Cai; Stephanie Lapping; Lale Ozcan; Rajasekhar Ramakrishnan; Richard G Pestell; Mukesh K Jain; Ira Tabas
Journal:  Blood       Date:  2018-12-01       Impact factor: 25.476

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.